SCHEMBL162194

SCHEMBL162194

O=C(O)c1cc(O)c[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL163392 0.78
SCHEMBL70598 0.75 SMN1; SMN2 (0.62)
SCHEMBL162193 0.75
SCHEMBL9346702 0.75 TDP1 (0.43)
SCHEMBL600362 0.73
SCHEMBL1928760 0.73
SCHEMBL5719789 0.73
SCHEMBL20929043 0.73
SCHEMBL1969273 0.73
SCHEMBL782011 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113582971-B Small molecule immunosuppressant, preparation method and application thereof 北京康辰药业股份有限公司 2023-10-20 CN claimed
CN-114276328-A Compound as small molecule immunosuppressant, preparation method and application thereof 北京康辰药业股份有限公司 2022-04-05 CN claimed
US-20050198745-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-09-15 US claimed
CN-113582971-B Small molecule immunosuppressant, preparation method and application thereof 北京康辰药业股份有限公司 2023-10-20 CN disclosed
CN-114276328-B Compound as small molecule immunosuppressant, preparation method and application thereof 北京康辰药业股份有限公司 2023-09-01 CN disclosed
CN-114276328-A Compound as small molecule immunosuppressant, preparation method and application thereof 北京康辰药业股份有限公司 2022-04-05 CN disclosed
US-9856210-B2 Pharmaceutical composition for prevention and treatment of amyotrophic lateral sclerosis KYOTO UNIVERSITY (JP) 2018-01-02 US disclosed
EP-2611437-B1 PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS UNIV KYOTO (JP) 2017-03-29 EP disclosed
US-20130225642-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS KYOTO UNIVERSITY (JP) 2013-08-29 US disclosed
EP-2611437-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS Kyoto University (JP) 2013-07-10 EP disclosed
CN-101648891-B Aryl cyclobutyl compound and application thereof in preparing weight-losing medicine BEIJING JIASHI LIANBO PHARMACEUTICAL TECHNOLOGY CORP 2012-11-28 CN disclosed
CN-1148387-A Substd. aminoalkylaminopyridine BYK GULDEN LOMBERG CHEM FAB (DE) 1997-04-23 CN disclosed
EP-0731801-A1 SUBSTITUTED AMINOALKYLAMINOPYRIDINES Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1996-09-18 EP disclosed
WO-1995015324-A1 SUBSTITUTED AMINOALKYLAMINOPYRIDINES BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1995-06-08 WO disclosed
US-4588817-A Antibiotic nodusmicins THE UPJOHN COMPANY (US) 1986-05-13 US disclosed
US-4461903-A Antibiotic nodusmicin derivatives THE UPJOHN COMPANY (US) 1984-07-24 US disclosed
US-4448970-A ANTIBIOTICS, BACTERICIDES THE UPJOHN COMPANY (US) 1984-05-15 US disclosed
US-4363922-A Esters of antibiotic nodusmicin THE UPJOHN COMPANY (US) 1982-12-14 US disclosed
US-4360683-A Antibiotic nodusmicin derivatives THE UPJOHN COMPANY (US) 1982-11-23 US disclosed
US-4351769-A Antibiotic composition of matter THE UPJOHN COMPANY (US) 1982-09-28 US disclosed